Cogent Biosciences, Inc. (COGT)
NASDAQ: COGT · Real-Time Price · USD
16.19
+0.61 (3.92%)
At close: Oct 9, 2025, 4:00 PM EDT
16.20
+0.01 (0.06%)
Pre-market: Oct 10, 2025, 8:00 AM EDT

Cogent Biosciences Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 20202017 - 2019
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2017 - 2019
-----7.87
Upgrade
Revenue Growth (YoY)
------65.02%
Upgrade
Gross Profit
-----7.87
Upgrade
Selling, General & Admin
48.7743.2834.3826.2119.6417.42
Upgrade
Research & Development
250.89232.66173.76121.6355.9172.65
Upgrade
Total Operating Expenses
299.66275.94208.13147.8475.5590.07
Upgrade
Operating Income
-299.66-275.94-208.13-147.84-75.55-82.2
Upgrade
Interest Income
13.9618.0913.083.990.470.14
Upgrade
Other Non-Operating Income (Expense)
1.941.992.643.612.817.25
Upgrade
Total Non-Operating Income (Expense)
15.920.0815.727.63.287.39
Upgrade
Pretax Income
-283.76-255.86-192.41-140.24-72.27-74.81
Upgrade
Net Income
-284.08-255.86-192.41-140.24-72.27-179.21
Upgrade
Net Income to Common
-284.08-255.86-192.41-140.24-72.27-179.21
Upgrade
Shares Outstanding (Basic)
11210480593911
Upgrade
Shares Outstanding (Diluted)
11210480593911
Upgrade
Shares Change (YoY)
22.35%30.38%35.61%51.66%249.52%45.42%
Upgrade
EPS (Basic)
-1.78-1.94-1.94-1.73-1.87-16.17
Upgrade
EPS (Diluted)
-1.78-1.94-1.94-1.73-1.87-16.17
Upgrade
Free Cash Flow
-234.65-208.36-156.42-125.5-60.48-35.85
Upgrade
Free Cash Flow Per Share
-2.09-2.01-1.96-2.14-1.56-3.24
Upgrade
Gross Margin
-----100.00%
Upgrade
Operating Margin
------1044.33%
Upgrade
Profit Margin
------950.43%
Upgrade
FCF Margin
------455.47%
Upgrade
EBITDA
-295.16-271.59-204.54-141.96-73.56-81.48
Upgrade
EBITDA Margin
------1035.18%
Upgrade
EBIT
-299.66-275.94-208.13-147.84-75.55-82.2
Upgrade
EBIT Margin
------1044.33%
Upgrade
Updated Jun 30, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q